VSP Bulloneria SpA has been acquired by Arcadia Sgr
The shareholders of VSP Bulloneria SpA (VSP) have sold a 80% stake in the company to Arcadia Sgr, an Italian private equity firm focused on mid-corporate investments, for US$15 million.
Marco Polato, second generation of the founding family, will retain a minority stake of 20% and will continue to lead the company as Chief Executive Officer. With the support of the new shareholders, VSP aims to consolidate its leadership position in the high-strength bolts segment and to strengthen its market penetration both in Italy and abroad. VSP was established in 1978 and is now a leading producer and distributor of high resistance fastener solutions for the energy, construction and industrial manufacturing sectors.
Arcadia Sgr is an Italian private equity firm focused on mid-corporate investments. Arcadia invests in unlisted small and mid-sized companies in need of replacement and management development and/or looking for expansion capital.
Oaklins' team in Italy advised the seller in this transaction.


Talk to the deal team
Related deals
STM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more